The Quality Assurance Team at BioSpring GmbH is responsible for ensuring that all manufacturing and analytical processes meet stringent cGMP standards, thereby safeguarding the quality and integrity of oligonucleotide products. They develop and implement quality management systems, conduct audits and inspections, and collaborate with cross-functional teams to ensure compliance with regulatory requirements. Their commitment to excellence helps to accelerate therapeutic programs while maintaining the highest quality standards crucial for advancing nucleic acid-based therapies.